ImmunityBio
IBRX
IBRX
62 hedge funds and large institutions have $172M invested in ImmunityBio in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
53% less capital invested
Capital invested by funds: $363M → $172M (-$191M)
Holders
62
Holding in Top 10
2
Calls
$1.43M
Puts
$249K
Top Buyers
| 1 | +$5.38M | |
| 2 | +$953K | |
| 3 | +$667K | |
| 4 |
CC
Callan Capital
La Jolla,
California
|
+$317K |
| 5 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
+$287K |
Top Sellers
| 1 | -$3.32M | |
| 2 | -$1.34M | |
| 3 | -$1.12M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$841K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$803K |